2024 Fundamentals and Advances in Immunotherapy in the Oncology Patient for the Advanced Practice Provider

Immunotherapeutics has changed the landscape of treatment modalities available to the cancer patient in both solid tumor and hematologic malignancies. Since the breakthrough of ipilimumab, there have been fast-paced and ongoing advancements in the field of immunotherapy, revolutionizing clinical management at a rapid pace.

This one-day virtual symposium will review fundamental concepts and recent advances in immunotherapy designed to meet the learning needs of advanced practice providers (APPs) and other allied health professionals. Clinical application in solid tumor and hematologic malignancies will be discussed as well as toxicity management, including immune-related adverse events resulting from immune checkpoint inhibition.

Experts will discuss the fundamentals of immune checkpoint blockade and CAR T cell therapy, as well as advancements in TIL and BITE therapy, novel combination therapy, and algorithmic management of immune-related adverse events. Toxicity management will be communicated through case study applications and demonstration of common, rare, and severe immune-related adverse events.

The overall goal of this program is to improve cancer patient outcomes by advancing the science, development, and application of cancer immunology and immunotherapy through fundamental understanding and clinical application.

Attendees of this symposium will receive access to an online syllabus, which includes select video recordings of the lectures.

Target Audience

The target audience for this course includes nurse practitioners, physician assistants, certified registered nurse anesthetists, physicians, and nurses who care for oncology patients. We are pleased to offer complimentary registration for nursing students and registrants residing in low and lower-middle income countries.

1. Describe the principles surrounding the immunity cycle
2. Explain fundamental principles of immunotherapeutic agents including immune checkpoint inhibition, CAR T cell, TIL, and BITE therapies.
3. Discuss the symptoms of Cytokine release Syndrome, ICANS, prolonged cytopenias and clinical management
4. Recognize and identify common, rare, and severe immune related adverse events attributed to immune checkpoint inhibition
5. Discuss clinical application of immune modulated agents in the oncology population

Registration Fees

• Physicians (MDs, PhDs, and DOs) $249
• Advanced Practice Providers: $199
• Nursing and Other Healthcare Professionals: $149
• Residents, Fellows, and APP Students: $25 (non-refundable)
• Industry Professionals*: $435
• Nursing Students and Registrants in Low-and Lower-Middle-Income Countries: Complimentary
• MSK Employees: Complimentary

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Registration Discounts & Promotions

• We are pleased to offer complimentary registration to nursing students and registrants residing in low and lower-middle income countries as defined by The World Bank. If you qualify for complimentary registration, please submit a request here for a complimentary promotion code to use at registration. 
• A registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend this program. If you are a member of one of these groups, please submit your request here for a promotion code to use at registration.
• Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Please note that the residents, fellows, and APP students rate is non-refundable.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Advanced Practice Providers

• American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
• American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
• National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME.

MSK Symposium Director 

Mary Kate Kasler, DNP, RN, ACNP-BC
Advanced Practice Provider

MSK Symposium Co-Director

Kerry E. Williams, MSN, RN, ANP-BC, AOCNP
Advanced Practice Provider 

MSK Advanced Practice Provider Sponsor 

Nicole Zakak, MS, RN, CPNP, CPHON®
Advanced Practice Provider Quality and Professional Development Director

MSK Symposium Physician Sponsor 

Sandra P. D’Angelo, MD
Associate Attending

MSK Symposium Planning Committee

Linda D’Andrea, MSN, RN, PPCNP, CPHON®
Advanced Practice Provider Specialist 

Kelly Haviland, PhD, RN, MSN, FNP-BC, TGNB-C
Advanced Practice Provider Manager
LGBTQI+ Clinical Consultant

Yelena Shames, MSN, RN, ACNP-BC, CNRN
Nurse Leader, Clinical Trials

Kristen Stasi, MSN, RN, OCN
Clinical Trials Nurse

Caroll Tipian, DNP, AGACNP-BC
Advanced Practice Provider

Joanne Wells, MSN, RN, ANP-BC, AOCNP
Advanced Practice Provider 

Invited Faculty 

Anne R. Bass, MD
Attending Physician, Hospital for Special Surgery
Professor of Clinical Medicine, Weill Cornell Medicine

MSK Faculty 

Ashley Ames, MSN, RN, AGPCNP-BC 
Advanced Practice Provider 

Lauren Banks, MD, PhD
Assistant Attending

Cameron Brennan, MD
Attending 

Claudia Calderon, MSN, AGPCNP-BC, OCN
Advanced Practice Provider

Angela Chan, DNP, AGPCNP-BC, RN, OCN
Advanced Practice Provider

Ruben Diaz, DNP, FNP-BC, BC-ADM, CDCES
Advanced Practice Provider

Stephanie Incardona, MSN, AGACNP-BC
Advanced Practice Provider

Liubou Korzun, MS, PA-C 
Advanced Practice Provider 

Alexander Lesokhin, MD, PhD 
Associate Attending 

Alina Markova, MD 
Associate Attending 

Alison Massey Tanner, MSN, RN, ANP-BC 
Advanced Practice Provider 

Katherine Nagel, MSN, FNP-BC
Advanced Practice Provider

Jaclyn Newfield, FNP-BC
Advanced Practice Provider

Katy Nickolaus, MS, PA-C 
Advanced Practice Provider 

Alexander Shoushtari, MD 
Assistant Attending 

James W. Smithy MD, MHS
Assistant Attending

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Wednesday, January 24, 2024